Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. | Cell Death Dis | 2022 | 35523772 | PubTator, text mining | PubMed |
| Identification of key candidate genes and biological pathways in the synovial tissue of patients with rheumatoid arthritis. | Exp Ther Med | 2022 | 35495609 | PubTator, text mining | PubMed |
| CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies. | J Exp Clin Cancer Res | 2022 | 35490245 | PubTator, text mining | PubMed |
| Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro. | PLoS One | 2022 | 35486574 | PubTator, text mining | PubMed |
| Upregulated of ANXA3, SORL1, and Neutrophils May Be Key Factors in the Progressionof Ankylosing Spondylitis. | Front Immunol | 2022 | 35464477 | PubTator, text mining | PubMed |
| Design of a new multi-epitope peptide vaccine for non-small cell Lung cancer via vaccinology methods: an in silico study. | Mol Biol Res Commun | 2022 | 35463817 | PubTator, text mining | PubMed |
| Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients. | Front Public Health | 2022 | 35462848 | PubTator, text mining | PubMed |
| Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy. | Int J Mol Sci | 2022 | 35457081 | PubTator, text mining | PubMed |
| Methylglyoxal Impairs Sister Chromatid Separation in Lymphocytes. | Int J Mol Sci | 2022 | 35456956 | PubTator, text mining | PubMed |
| Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions. | Diagnostics (Basel) | 2022 | 35454025 | PubTator, text mining | PubMed |
| Personalized Diagnosis in Differentiated Thyroid Cancers by Molecular and Functional Imaging Biomarkers: Present and Future. | Diagnostics (Basel) | 2022 | 35453992 | PubTator, text mining | PubMed |
| The CpG Island-Binding Protein SAMD1 Contributes to an Unfavorable Gene Signature in HepG2 Hepatocellular Carcinoma Cells. | Biology (Basel) | 2022 | 35453756 | PubTator, text mining | PubMed |
| miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6. | Clin Exp Metastasis | 2022 | 35449340 | PubTator, text mining | PubMed |
| Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription. | Nat Commun | 2022 | 35440621 | PubTator, text mining | PubMed |
| Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer. | Breast Cancer (Dove Med Press) | 2022 | 35437353 | PubTator, text mining | PubMed |
| Construction of a circRNA-Mediated ceRNA Network Reveals Novel Biomarkers for Aortic Dissection. | Int J Gen Med | 2022 | 35437351 | PubTator, text mining | PubMed |
| The Role of Copy Number Variants in Gene Co-Expression Patterns for Luminal B Breast Tumors. | Front Genet | 2022 | 35432489 | PubTator, text mining | PubMed |
| MiR-300 Alleviates Cell Proliferation and Migration and Facilitates Cell Apoptosis by Targeting c-Met in Gastric Cancer. | J Oncol | 2022 | 35419054 | PubTator, text mining | PubMed |
| The Interplay of Cohesin and RNA Processing Factors: The Impact of Their Alterations on Genome Stability. | Int J Mol Sci | 2022 | 35409298 | PubTator, text mining | PubMed |
| Transcription Factors with Targeting Potential in Gliomas. | Int J Mol Sci | 2022 | 35409080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=29